NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2018-10, Vol.29 Suppl 8, p.viii151
Hauptverfasser: Winther, S B, Skuladottir, H, Hofsli, E, Shah, C-H, Yilmaz, M K, Österlund, P J, Berglund, Å, Glimelius, B, Qvortrup, C, Sorbye, H, Pfeiffer, P
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page viii151
container_title Annals of oncology
container_volume 29 Suppl 8
creator Winther, S B
Skuladottir, H
Hofsli, E
Shah, C-H
Yilmaz, M K
Österlund, P J
Berglund, Å
Glimelius, B
Qvortrup, C
Sorbye, H
Pfeiffer, P
description
doi_str_mv 10.1093/annonc/mdy281.003
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy281_003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32136253</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2263-d679dc148364dd11b440f18544c10d11bad238f814702a2016f916ecb52fbd2e3</originalsourceid><addsrcrecordid>eNpFkctu1DAUhi1URKeFB2CDvOws3PqWTNJdld5GqhipwDpyfGGMHDuyPW2Ht-wb4VEorKxjne8_v_QB8Jngc4JbdiG8D15ejGpPG3KOMXsHFqSqW9RgTo7AAreUoVXF-DE4SekXxrhuafsBHDNKWE0rtgCvXzeP1-uuvYRXMAqvwmh_awWnrUgartcwRysclGGcRLT-JzQ2poyc9RpOwjkrsn3S0OycQyoUZAw-5K2OYtrDs2-ILOGzzVsYtdrJknvYQSVtsL6QwcP_u5uXJbQeBqd0hKUJNFFYV65kq31Oc86os0i5fMnSyYWoZT7UE14W6GzsHrvlR_DeCJf0p7_vKfhxe_O9u0cPm7t1d_WAJKU1Q6petUoS3rCaK0XIwDk2pKk4lwQfZqEoa0xD-ApTQTGpTUtqLYeKmkFRzU4BmXNlDClFbfop2lHEfU9wf9DTz3r6WU9f9BTmy8xMu2HU6h_x5oP9ARgJkGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Winther, S B ; Skuladottir, H ; Hofsli, E ; Shah, C-H ; Yilmaz, M K ; Österlund, P J ; Berglund, Å ; Glimelius, B ; Qvortrup, C ; Sorbye, H ; Pfeiffer, P</creator><creatorcontrib>Winther, S B ; Skuladottir, H ; Hofsli, E ; Shah, C-H ; Yilmaz, M K ; Österlund, P J ; Berglund, Å ; Glimelius, B ; Qvortrup, C ; Sorbye, H ; Pfeiffer, P</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy281.003</identifier><identifier>PMID: 32136253</identifier><language>eng</language><publisher>England</publisher><ispartof>Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii151</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2263-d679dc148364dd11b440f18544c10d11bad238f814702a2016f916ecb52fbd2e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32136253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Winther, S B</creatorcontrib><creatorcontrib>Skuladottir, H</creatorcontrib><creatorcontrib>Hofsli, E</creatorcontrib><creatorcontrib>Shah, C-H</creatorcontrib><creatorcontrib>Yilmaz, M K</creatorcontrib><creatorcontrib>Österlund, P J</creatorcontrib><creatorcontrib>Berglund, Å</creatorcontrib><creatorcontrib>Glimelius, B</creatorcontrib><creatorcontrib>Qvortrup, C</creatorcontrib><creatorcontrib>Sorbye, H</creatorcontrib><creatorcontrib>Pfeiffer, P</creatorcontrib><title>NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpFkctu1DAUhi1URKeFB2CDvOws3PqWTNJdld5GqhipwDpyfGGMHDuyPW2Ht-wb4VEorKxjne8_v_QB8Jngc4JbdiG8D15ejGpPG3KOMXsHFqSqW9RgTo7AAreUoVXF-DE4SekXxrhuafsBHDNKWE0rtgCvXzeP1-uuvYRXMAqvwmh_awWnrUgartcwRysclGGcRLT-JzQ2poyc9RpOwjkrsn3S0OycQyoUZAw-5K2OYtrDs2-ILOGzzVsYtdrJknvYQSVtsL6QwcP_u5uXJbQeBqd0hKUJNFFYV65kq31Oc86os0i5fMnSyYWoZT7UE14W6GzsHrvlR_DeCJf0p7_vKfhxe_O9u0cPm7t1d_WAJKU1Q6petUoS3rCaK0XIwDk2pKk4lwQfZqEoa0xD-ApTQTGpTUtqLYeKmkFRzU4BmXNlDClFbfop2lHEfU9wf9DTz3r6WU9f9BTmy8xMu2HU6h_x5oP9ARgJkGQ</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Winther, S B</creator><creator>Skuladottir, H</creator><creator>Hofsli, E</creator><creator>Shah, C-H</creator><creator>Yilmaz, M K</creator><creator>Österlund, P J</creator><creator>Berglund, Å</creator><creator>Glimelius, B</creator><creator>Qvortrup, C</creator><creator>Sorbye, H</creator><creator>Pfeiffer, P</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)</title><author>Winther, S B ; Skuladottir, H ; Hofsli, E ; Shah, C-H ; Yilmaz, M K ; Österlund, P J ; Berglund, Å ; Glimelius, B ; Qvortrup, C ; Sorbye, H ; Pfeiffer, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2263-d679dc148364dd11b440f18544c10d11bad238f814702a2016f916ecb52fbd2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Winther, S B</creatorcontrib><creatorcontrib>Skuladottir, H</creatorcontrib><creatorcontrib>Hofsli, E</creatorcontrib><creatorcontrib>Shah, C-H</creatorcontrib><creatorcontrib>Yilmaz, M K</creatorcontrib><creatorcontrib>Österlund, P J</creatorcontrib><creatorcontrib>Berglund, Å</creatorcontrib><creatorcontrib>Glimelius, B</creatorcontrib><creatorcontrib>Qvortrup, C</creatorcontrib><creatorcontrib>Sorbye, H</creatorcontrib><creatorcontrib>Pfeiffer, P</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Winther, S B</au><au>Skuladottir, H</au><au>Hofsli, E</au><au>Shah, C-H</au><au>Yilmaz, M K</au><au>Österlund, P J</au><au>Berglund, Å</au><au>Glimelius, B</au><au>Qvortrup, C</au><au>Sorbye, H</au><au>Pfeiffer, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29 Suppl 8</volume><spage>viii151</spage><pages>viii151-</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pmid>32136253</pmid><doi>10.1093/annonc/mdy281.003</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii151
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdy281_003
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title NORDIC9: A randomized phase II trial comparing first-line palliative full-dose monotherapy (S-1) with reduced dose-combination therapy (SOx) in older and frail patients with metastatic colorectal cancer (mCRC)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T17%3A55%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NORDIC9:%20A%20randomized%20phase%20II%20trial%20comparing%20first-line%20palliative%20full-dose%20monotherapy%20(S-1)%20with%20reduced%20dose-combination%20therapy%20(SOx)%20in%20older%20and%20frail%20patients%20with%20metastatic%20colorectal%20cancer%20(mCRC)&rft.jtitle=Annals%20of%20oncology&rft.au=Winther,%20S%20B&rft.date=2018-10&rft.volume=29%20Suppl%208&rft.spage=viii151&rft.pages=viii151-&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy281.003&rft_dat=%3Cpubmed_cross%3E32136253%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32136253&rfr_iscdi=true